ProPhase Labs, Inc.
PRPH
$0.11
-$0.02-16.57%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -6.84M | -4.47M | 3.97M | -34.36M | -6.59M |
| Total Depreciation and Amortization | 1.06M | 1.44M | 1.60M | 1.64M | 1.64M |
| Total Amortization of Deferred Charges | 964.00K | 477.00K | 372.00K | 502.00K | 614.00K |
| Total Other Non-Cash Items | 2.38M | 1.47M | -7.05M | 12.26M | 1.03M |
| Change in Net Operating Assets | -1.04M | 844.00K | -2.27M | 16.43M | -733.00K |
| Cash from Operations | -3.49M | -247.00K | -3.38M | -3.52M | -4.04M |
| Capital Expenditure | -- | -- | -- | -40.00K | 1.00K |
| Sale of Property, Plant, and Equipment | 0.00 | 67.00K | 53.00K | 0.00 | 79.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | 0.00 | 800.00K | 0.00 | -177.00K |
| Cash from Investing | 0.00 | 67.00K | 853.00K | -40.00K | -97.00K |
| Total Debt Issued | 5.23M | 983.00K | 204.00K | 1.53M | 4.47M |
| Total Debt Repaid | -1.51M | -1.00M | -1.51M | -1.76M | -1.60M |
| Issuance of Common Stock | 0.00 | 280.00K | 3.28M | 2.97M | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 0.00 | -35.00K | 994.00K | -6.00K |
| Cash from Financing | 3.72M | 261.00K | 1.94M | 3.74M | 2.86M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 236.00K | 81.00K | -590.00K | 177.00K | -1.28M |